✦ LIBER ✦

Combinatorial Pharmacologic Effects of Gemcitabine and its Metabolite dFdU

✍ Scribed by Prof. Alexey Benyumov; Prof. Vadim J. Gurvich; Dr. Lev G. Lis; Brent W. Williams; Prof. Mark N. Kirstein

Book ID: 102804359
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 559 KB
Volume: 6
Category: Article
ISSN: 1860-7179
DOI: 10.1002/cmdc.201000447

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High sensitive assay employing column sw

High sensitive assay employing column switching chromatography to enable simultaneous quantification of an amide prodrug of gemcitabine (LY2334737), gemcitabine, and its metabolite dFdU in human plasma by LC–MS/MS

✍ Wickremsinhe, Enaksha R.; Lee, Lisa B.; Schmalz, Chris A.; Torchia, John; Ruterb 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 660 KB

In vitro studies on the immunosuppressiv

In vitro studies on the immunosuppressive effect of 2′,2′-difluorodeoxycytidine (dFdC) and its metabolite 2′,2′-difluorodeoxyuridine (dFdU)

✍ Martin Tiefenthaler; Florian Hohla; Eveline Irschick; Elisabeth Strasser-Wozak; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Simultaneous determination of gemcitabin

Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry

✍ Elena Marangon; Federica Sala; Orazio Caffo; Enzo Galligioni; Maurizio D'Incalci 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 1 views

## Abstract Gemcitabine, 2′,2′‐difluoro‐2′‐deoxycytidine (dFdC) is a pyrimidine antimetabolite employed against several human malignancies. It undergoes intracellular activation to the pharmacologically active triphosphate form (dFdCTP) and metabolic inactivation to the metabolite 2′,2′‐difluorodeo

Anticholinergic cardiac effects of proca

Anticholinergic cardiac effects of procainamide and its N-acetylated metabolite: experimental pharmacologic and radioligand binding studies

✍ M. Boucher; C. Chassaing; P. Laborde; C. Breysse; A. Herbet; P. Duchêne-Marullaz 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Population Pharmacokinetics of Gemcitabi

Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients

✍ Emiko Sugiyama, Dr Nahoko Kaniwa, Su-Ryang Kim, Ryuichi Hasegawa, Yoshiro Saito, 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 290 KB

Pharmacological Properties of Diclofenac

Pharmacological Properties of Diclofenac Sodium and Its Metabolites

✍ Menassé, R.; Hedwall, P. R.; Kraetz, J.; Pericin, C.; Riesterer, L.; Sallmann, A 📂 Article 📅 1978 🏛 Informa plc 🌐 English ⚖ 970 KB